What is the current market valuation of the pediatric cardiac surgery market?

The pediatric cardiac surgery market was valued at 3.5 USD Billion in 2024. Read More

What is the projected market size for the pediatric cardiac surgery market by 2035?

The market is projected to reach 5.2 USD Billion by 2035. Read More

What is the expected CAGR for the pediatric cardiac surgery market during the forecast period 2025 - 2035?

The expected CAGR for the pediatric cardiac surgery market is 3.66% during the forecast period 2025 - 2035. Read More

Which surgical procedure type is expected to generate the highest revenue in the pediatric cardiac surgery market?

Open heart surgery is anticipated to generate the highest revenue, with a projected valuation increase from 1.4 to 2.0 USD Billion. Read More

How does the market for minimally invasive surgery compare to catheter-based interventions?

Minimally invasive surgery is projected to grow from 0.9 to 1.4 USD Billion, while catheter-based interventions are expected to increase from 0.8 to 1.2 USD Billion. Read More

What age group is expected to contribute the most to the pediatric cardiac surgery market?

Children are likely to contribute the most, with a projected market size increase from 1.2 to 1.8 USD Billion. Read More

Which congenital heart defect is projected to have the highest market growth?

Ventricular septal defect is projected to grow from 1.1 to 1.6 USD Billion, indicating strong market potential. Read More

What healthcare setting is expected to dominate the pediatric cardiac surgery market?

Pediatric cardiac centers are anticipated to dominate, with a projected increase from 1.4 to 2.0 USD Billion. Read More

What surgical technique is expected to see significant growth in the pediatric cardiac surgery market?

Cardiopulmonary bypass is expected to see significant growth, with projections rising from 1.4 to 2.0 USD Billion. Read More

Who are the key players in the pediatric cardiac surgery market?

Key players include Boston Scientific, Medtronic, Abbott Laboratories, and Edwards Lifesciences, among others. Read More

Pediatric Cardiac Surgery Market

ID: MRFR/HC/65720-HCR

200 Pages

Nidhi Mandole

Last Updated: May 04, 2026

Pediatric Cardiac Surgery Market Research Report: Size, Share, Trend Analysis By Age Group Outlook (Neonates, Infants, Children, Adolescents) By Healthcare Setting Outlook (Pediatric Cardiac Centers, General Hospitals, Specialized Clinics, Research Institutions) By Surgical Techniques Outlook (Cardiopulmonary Bypass, Off-Pump Surgery, Robotic Surgery, Hybrid Procedures) By Surgical Procedure Type Outlook (Open Heart Surgery, Minimally Invasive Surgery, Catheter-Based Interventions, Transplantation) By Congenital Heart Defects Outlook (Atrial Septal Defect, Ventricular Septal Defect, Tetralogy of Fallot, Coarctation of Aorta) – Growth Outlook & Industry Forecast To 2035

pediatric cardiac surgery market Infographic

Summary Table of Contents Segmentation Download PDF

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Surgical Procedure Type (USD Billion) | |
  1. 4.1.1 Open Heart Surgery | |
  2. 4.1.2 Minimally Invasive Surgery | |
  3. 4.1.3 Catheter-Based Interventions | |
  4. 4.1.4 Transplantation |
2. 4.2 Healthcare, BY Age Group (USD Billion) | |
  1. 4.2.1 Neonates | |
  2. 4.2.2 Infants | |
  3. 4.2.3 Children | |
  4. 4.2.4 Adolescents |
3. 4.3 Healthcare, BY Congenital Heart Defects (USD Billion) | |
  1. 4.3.1 Atrial Septal Defect | |
  2. 4.3.2 Ventricular Septal Defect | |
  3. 4.3.3 Tetralogy of Fallot | |
  4. 4.3.4 Coarctation of Aorta |
4. 4.4 Healthcare, BY Healthcare Setting (USD Billion) | |
  1. 4.4.1 Pediatric Cardiac Centers | |
  2. 4.4.2 General Hospitals | |
  3. 4.4.3 Specialized Clinics | |
  4. 4.4.4 Research Institutions |
5. 4.5 Healthcare, BY Surgical Techniques (USD Billion) | |
  1. 4.5.1 Cardiopulmonary Bypass | |
  2. 4.5.2 Off-Pump Surgery | |
  3. 4.5.3 Robotic Surgery | |
  4. 4.5.4 Hybrid Procedures |
6. 4.6 Healthcare, BY Region (USD Billion) | |
  1. 4.6.1 North America | | |
    1. 4.6.1.1 US | | |
    2. 4.6.1.2 Canada | |
  2. 4.6.2 Europe | | |
    1. 4.6.2.1 Germany | | |
    2. 4.6.2.2 UK | | |
    3. 4.6.2.3 France | | |
    4. 4.6.2.4 Russia | | |
    5. 4.6.2.5 Italy | | |
    6. 4.6.2.6 Spain | | |
    7. 4.6.2.7 Rest of Europe | |
  3. 4.6.3 APAC | | |
    1. 4.6.3.1 China | | |
    2. 4.6.3.2 India | | |
    3. 4.6.3.3 Japan | | |
    4. 4.6.3.4 South Korea | | |
    5. 4.6.3.5 Malaysia | | |
    6. 4.6.3.6 Thailand | | |
    7. 4.6.3.7 Indonesia | | |
    8. 4.6.3.8 Rest of APAC | |
  4. 4.6.4 South America | | |
    1. 4.6.4.1 Brazil | | |
    2. 4.6.4.2 Mexico | | |
    3. 4.6.4.3 Argentina | | |
    4. 4.6.4.4 Rest of South America | |
  5. 4.6.5 MEA | | |
    1. 4.6.5.1 GCC Countries | | |
    2. 4.6.5.2 South Africa | | |
    3. 4.6.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Boston Scientific (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 Medtronic (US) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Abbott Laboratories (US) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Edwards Lifesciences (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Sorin Group (IT) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Terumo Corporation (JP) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 LivaNova (GB) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Cardinal Health (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies | |
  9. 5.2.9 B. Braun Melsungen AG (DE) | | |
    1. 5.2.9.1 Financial Overview | | |
    2. 5.2.9.2 Products Offered | | |
    3. 5.2.9.3 Key Developments | | |
    4. 5.2.9.4 SWOT Analysis | | |
    5. 5.2.9.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
7. 6.4 US MARKET ANALYSIS BY AGE GROUP |
8. 6.5 US MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
9. 6.6 US MARKET ANALYSIS BY HEALTHCARE SETTING |
10. 6.7 US MARKET ANALYSIS BY SURGICAL TECHNIQUES |
11. 6.8 CANADA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
12. 6.9 CANADA MARKET ANALYSIS BY AGE GROUP |
13. 6.10 CANADA MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
14. 6.11 CANADA MARKET ANALYSIS BY HEALTHCARE SETTING |
15. 6.12 CANADA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
16. 6.13 EUROPE MARKET ANALYSIS |
17. 6.14 GERMANY MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
18. 6.15 GERMANY MARKET ANALYSIS BY AGE GROUP |
19. 6.16 GERMANY MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
20. 6.17 GERMANY MARKET ANALYSIS BY HEALTHCARE SETTING |
21. 6.18 GERMANY MARKET ANALYSIS BY SURGICAL TECHNIQUES |
22. 6.19 UK MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
23. 6.20 UK MARKET ANALYSIS BY AGE GROUP |
24. 6.21 UK MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
25. 6.22 UK MARKET ANALYSIS BY HEALTHCARE SETTING |
26. 6.23 UK MARKET ANALYSIS BY SURGICAL TECHNIQUES |
27. 6.24 FRANCE MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
28. 6.25 FRANCE MARKET ANALYSIS BY AGE GROUP |
29. 6.26 FRANCE MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
30. 6.27 FRANCE MARKET ANALYSIS BY HEALTHCARE SETTING |
31. 6.28 FRANCE MARKET ANALYSIS BY SURGICAL TECHNIQUES |
32. 6.29 RUSSIA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
33. 6.30 RUSSIA MARKET ANALYSIS BY AGE GROUP |
34. 6.31 RUSSIA MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
35. 6.32 RUSSIA MARKET ANALYSIS BY HEALTHCARE SETTING |
36. 6.33 RUSSIA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
37. 6.34 ITALY MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
38. 6.35 ITALY MARKET ANALYSIS BY AGE GROUP |
39. 6.36 ITALY MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
40. 6.37 ITALY MARKET ANALYSIS BY HEALTHCARE SETTING |
41. 6.38 ITALY MARKET ANALYSIS BY SURGICAL TECHNIQUES |
42. 6.39 SPAIN MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
43. 6.40 SPAIN MARKET ANALYSIS BY AGE GROUP |
44. 6.41 SPAIN MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
45. 6.42 SPAIN MARKET ANALYSIS BY HEALTHCARE SETTING |
46. 6.43 SPAIN MARKET ANALYSIS BY SURGICAL TECHNIQUES |
47. 6.44 REST OF EUROPE MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
48. 6.45 REST OF EUROPE MARKET ANALYSIS BY AGE GROUP |
49. 6.46 REST OF EUROPE MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
50. 6.47 REST OF EUROPE MARKET ANALYSIS BY HEALTHCARE SETTING |
51. 6.48 REST OF EUROPE MARKET ANALYSIS BY SURGICAL TECHNIQUES |
52. 6.49 APAC MARKET ANALYSIS |
53. 6.50 CHINA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
54. 6.51 CHINA MARKET ANALYSIS BY AGE GROUP |
55. 6.52 CHINA MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
56. 6.53 CHINA MARKET ANALYSIS BY HEALTHCARE SETTING |
57. 6.54 CHINA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
58. 6.55 INDIA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
59. 6.56 INDIA MARKET ANALYSIS BY AGE GROUP |
60. 6.57 INDIA MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
61. 6.58 INDIA MARKET ANALYSIS BY HEALTHCARE SETTING |
62. 6.59 INDIA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
63. 6.60 JAPAN MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
64. 6.61 JAPAN MARKET ANALYSIS BY AGE GROUP |
65. 6.62 JAPAN MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
66. 6.63 JAPAN MARKET ANALYSIS BY HEALTHCARE SETTING |
67. 6.64 JAPAN MARKET ANALYSIS BY SURGICAL TECHNIQUES |
68. 6.65 SOUTH KOREA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
69. 6.66 SOUTH KOREA MARKET ANALYSIS BY AGE GROUP |
70. 6.67 SOUTH KOREA MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
71. 6.68 SOUTH KOREA MARKET ANALYSIS BY HEALTHCARE SETTING |
72. 6.69 SOUTH KOREA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
73. 6.70 MALAYSIA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
74. 6.71 MALAYSIA MARKET ANALYSIS BY AGE GROUP |
75. 6.72 MALAYSIA MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
76. 6.73 MALAYSIA MARKET ANALYSIS BY HEALTHCARE SETTING |
77. 6.74 MALAYSIA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
78. 6.75 THAILAND MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
79. 6.76 THAILAND MARKET ANALYSIS BY AGE GROUP |
80. 6.77 THAILAND MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
81. 6.78 THAILAND MARKET ANALYSIS BY HEALTHCARE SETTING |
82. 6.79 THAILAND MARKET ANALYSIS BY SURGICAL TECHNIQUES |
83. 6.80 INDONESIA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
84. 6.81 INDONESIA MARKET ANALYSIS BY AGE GROUP |
85. 6.82 INDONESIA MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
86. 6.83 INDONESIA MARKET ANALYSIS BY HEALTHCARE SETTING |
87. 6.84 INDONESIA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
88. 6.85 REST OF APAC MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
89. 6.86 REST OF APAC MARKET ANALYSIS BY AGE GROUP |
90. 6.87 REST OF APAC MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
91. 6.88 REST OF APAC MARKET ANALYSIS BY HEALTHCARE SETTING |
92. 6.89 REST OF APAC MARKET ANALYSIS BY SURGICAL TECHNIQUES |
93. 6.90 SOUTH AMERICA MARKET ANALYSIS |
94. 6.91 BRAZIL MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
95. 6.92 BRAZIL MARKET ANALYSIS BY AGE GROUP |
96. 6.93 BRAZIL MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
97. 6.94 BRAZIL MARKET ANALYSIS BY HEALTHCARE SETTING |
98. 6.95 BRAZIL MARKET ANALYSIS BY SURGICAL TECHNIQUES |
99. 6.96 MEXICO MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
100. 6.97 MEXICO MARKET ANALYSIS BY AGE GROUP |
101. 6.98 MEXICO MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
102. 6.99 MEXICO MARKET ANALYSIS BY HEALTHCARE SETTING |
103. 6.100 MEXICO MARKET ANALYSIS BY SURGICAL TECHNIQUES |
104. 6.101 ARGENTINA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
105. 6.102 ARGENTINA MARKET ANALYSIS BY AGE GROUP |
106. 6.103 ARGENTINA MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
107. 6.104 ARGENTINA MARKET ANALYSIS BY HEALTHCARE SETTING |
108. 6.105 ARGENTINA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
109. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
110. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY AGE GROUP |
111. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
112. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY HEALTHCARE SETTING |
113. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
114. 6.111 MEA MARKET ANALYSIS |
115. 6.112 GCC COUNTRIES MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
116. 6.113 GCC COUNTRIES MARKET ANALYSIS BY AGE GROUP |
117. 6.114 GCC COUNTRIES MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
118. 6.115 GCC COUNTRIES MARKET ANALYSIS BY HEALTHCARE SETTING |
119. 6.116 GCC COUNTRIES MARKET ANALYSIS BY SURGICAL TECHNIQUES |
120. 6.117 SOUTH AFRICA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
121. 6.118 SOUTH AFRICA MARKET ANALYSIS BY AGE GROUP |
122. 6.119 SOUTH AFRICA MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
123. 6.120 SOUTH AFRICA MARKET ANALYSIS BY HEALTHCARE SETTING |
124. 6.121 SOUTH AFRICA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
125. 6.122 REST OF MEA MARKET ANALYSIS BY SURGICAL PROCEDURE TYPE |
126. 6.123 REST OF MEA MARKET ANALYSIS BY AGE GROUP |
127. 6.124 REST OF MEA MARKET ANALYSIS BY CONGENITAL HEART DEFECTS |
128. 6.125 REST OF MEA MARKET ANALYSIS BY HEALTHCARE SETTING |
129. 6.126 REST OF MEA MARKET ANALYSIS BY SURGICAL TECHNIQUES |
130. 6.127 KEY BUYING CRITERIA OF HEALTHCARE |
131. 6.128 RESEARCH PROCESS OF MRFR |
132. 6.129 DRO ANALYSIS OF HEALTHCARE |
133. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
134. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
135. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE |
136. 6.133 HEALTHCARE, BY SURGICAL PROCEDURE TYPE, 2024 (% SHARE) |
137. 6.134 HEALTHCARE, BY SURGICAL PROCEDURE TYPE, 2024 TO 2035 (USD Billion) |
138. 6.135 HEALTHCARE, BY AGE GROUP, 2024 (% SHARE) |
139. 6.136 HEALTHCARE, BY AGE GROUP, 2024 TO 2035 (USD Billion) |
140. 6.137 HEALTHCARE, BY CONGENITAL HEART DEFECTS, 2024 (% SHARE) |
141. 6.138 HEALTHCARE, BY CONGENITAL HEART DEFECTS, 2024 TO 2035 (USD Billion) |
142. 6.139 HEALTHCARE, BY HEALTHCARE SETTING, 2024 (% SHARE) |
143. 6.140 HEALTHCARE, BY HEALTHCARE SETTING, 2024 TO 2035 (USD Billion) |
144. 6.141 HEALTHCARE, BY SURGICAL TECHNIQUES, 2024 (% SHARE) |
145. 6.142 HEALTHCARE, BY SURGICAL TECHNIQUES, 2024 TO 2035 (USD Billion) |
146. 6.143 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
147. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
148. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.2.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.2.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.2.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.2.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
149. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.3.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.3.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.3.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.3.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
150. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.4.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.4.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.4.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.4.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
151. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.5.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.5.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.5.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.5.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
152. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.6.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.6.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.6.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.6.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
153. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.7.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.7.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.7.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.7.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
154. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.8.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.8.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.8.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.8.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
155. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.9.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.9.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.9.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.9.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
156. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.10.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.10.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.10.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.10.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
157. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.11.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.11.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.11.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.11.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
158. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.12.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.12.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.12.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.12.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
159. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.13.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.13.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.13.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.13.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
160. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.14.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.14.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.14.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.14.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
161. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.15.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.15.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.15.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.15.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
162. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.16.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.16.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.16.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.16.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
163. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.17.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.17.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.17.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.17.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
164. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.18.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.18.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.18.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.18.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
165. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.19.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.19.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.19.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.19.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
166. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.20.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.20.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.20.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.20.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
167. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.21.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.21.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.21.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.21.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
168. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.22.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.22.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.22.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.22.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
169. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.23.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.23.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.23.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.23.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
170. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.24.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.24.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.24.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.24.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
171. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.25.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.25.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.25.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.25.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
172. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.26.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.26.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.26.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.26.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
173. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.27.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.27.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.27.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.27.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
174. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.28.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.28.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.28.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.28.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
175. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.29.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.29.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.29.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.29.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
176. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY SURGICAL PROCEDURE TYPE, 2025-2035 (USD Billion) | |
  2. 7.30.2 BY AGE GROUP, 2025-2035 (USD Billion) | |
  3. 7.30.3 BY CONGENITAL HEART DEFECTS, 2025-2035 (USD Billion) | |
  4. 7.30.4 BY HEALTHCARE SETTING, 2025-2035 (USD Billion) | |
  5. 7.30.5 BY SURGICAL TECHNIQUES, 2025-2035 (USD Billion) |
177. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
178. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Surgical Procedure Type (USD Billion, 2025-2035)

Open Heart Surgery
Minimally Invasive Surgery
Catheter-Based Interventions
Transplantation

Healthcare By Age Group (USD Billion, 2025-2035)

Neonates
Infants
Children
Adolescents

Healthcare By Congenital Heart Defects (USD Billion, 2025-2035)

Atrial Septal Defect
Ventricular Septal Defect
Tetralogy of Fallot
Coarctation of Aorta

Healthcare By Healthcare Setting (USD Billion, 2025-2035)

Pediatric Cardiac Centers
General Hospitals
Specialized Clinics
Research Institutions

Healthcare By Surgical Techniques (USD Billion, 2025-2035)

Cardiopulmonary Bypass
Off-Pump Surgery
Robotic Surgery
Hybrid Procedures

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓